Multimodal analgesia with ropivacaine wound infiltration and intravenous flurbiprofen axetil provides enhanced analgesic effects after radical thyroidectomy: a randomized controlled trial

Table 1 Demographic characteristics and intraoperative data

	Group M (n = 20)	Group C (n = 20)	Statistics	P
Age (years)	42.4 ± 8.7	39.5 ± 8.4	1.066^a	0.293
Sex (M/F)	4/16	6/14	0.533^b	0.465
Weight (kg)	65.4 ± 10.3	63.6 ± 12.4	0.479^a	0.635
BMI (kg/m²)	24.2 ± 3.9	23.3 ± 3.6	0.801^a	0.428
Type of operation, n (%)
Hemithyroidectomy	13 (65.0%)	10 (50.0%)	0.921^b	0.337
Total thyroidectomy	7 (35.0%)	10 (50.0%)	0.921^b	0.337
Duration of surgery (s)	68.5 ± 32.2	66.7 ± 23.2	0.203^a	0.840
Consciousness recovery time (s)	7.0 ± 4.1	6.4 ± 3.5	0.543^a	0.590
Extubation time (s)	10.0 ± 5.5	11.1 ± 5.9	0.582^a	0.564
Remifentanil (mg)	0.626 ± 0.268	0.645 ± 0.238	0.238^a	0.813

Data are presented as mean ± SD or n (%). Group M, multimodal analgesia group who received ropivacaine locally plus intravenous flurbiprofen axetil; Group C, control group who received a single dose of tramadol; BMI Body mass index; ^a, t value; ^b, Chi-square value

ISSN: 1471-2253